Search

6 results for “Beta blocker”

• Research LetterOpen Access

  Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19 Cardiac Conditions?

  Shridhar Dwivedi, Vinod Sharma, C. R. Patil

  Vol. 13 · Issue 1 · pp. 95–96

  https://doi.org/10.1177/0976500X221080202
  Full text ↗PDF

• Case ReportOpen Access

  Sick sinus syndrome associated with topical timolol maleate instillation

  Harpreet S. Walia, Sandeep S. Walia, Matthew E. Emanuel

  Vol. 2 · Issue 4 · pp. 300–302

  https://doi.org/10.4103/0976-500X.85946
  Full text ↗PDF

• Research PaperOpen Access

  Assessment of demographics, treatment strategies, and evidence‑based medicine use among diabetic and non‑diabetic patients with acute coronary syndrome: A cohort study

  Bhavik S. Shah, Shrikalp S. Deshpande

  Vol. 5 · Issue 2 · pp. 139–144

  https://doi.org/10.4103/0976-500X.130058
  Full text ↗PDF

• Case ReportOpen Access

  Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy

  Maria Giuseppa Sullo, Domenico Perri, Michelina Sibilio, Concetta Rafaniello, Annamaria Fucile

  Vol. 6 · Issue 1 · pp. 45–48

  https://doi.org/10.4103/0976-500X.149148
  Full text ↗PDF

• Research LetterOpen Access

  Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis

  Sean A. Sassano-Higgins, Michele T. Pato

  Vol. 6 · Issue 1 · pp. 36–38

  https://doi.org/10.4103/0976-500X.149144
  Full text ↗PDF

• Case ReportOpen Access

  Recurrence of atrial fibrillation after switching from brand to generic atenolol

  Luca Gallelli, Francesca Maida, Orietta Staltari, Pierandrea Rende, Emilio Russo, Benedetto Caroleo

  Vol. 5 · Issue 1 · pp. 158–160

  https://doi.org/10.4103/0976-500X.149146
  Full text ↗PDF